WebMar 7, 2024 · VANCOUVER, BC – March 07, 2024 ‐ BioNxt Solutions Inc. (“BioNxt” or the “Company”) (CSE: BNXT / OTC: BNXTF / FSE: BXT) is pleased to report that it has signed a definitive technology transfer and patent assignment agreement (the “Agreement”) to acquire certain technology and intellectual property assets and rights related to a novel … WebNov 21, 2024 · BioNxt Solutions Inc. is a bioscience accelerator focused on next-generation drug formulations and delivery systems, diagnostic screening tests, and new active pharmaceutical production and evaluation, including: precision transdermal and oral dissolvable drug formulations; rapid, low-cost infectious disease and oral health …
Ecosystem 2.0: Climbing to the next level (2024)
WebApr 13, 2024 · BioNxt Solutions Inc. a publié ses résultats pour l'exercice clos le 31 décembre 2024. Pour l'ensemble de l'exercice, la société a déclaré un chiffre d'affaires … WebMar 21, 2024 · A high-level overview of BioNxt Solutions Inc. (BNXTF) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and … september holidays us 2023
BIOTECH Innovationsschub - BioNxt Solutions, Evotec, Morphosys
WebDec 7, 2024 · NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. VANCOUVER, BC / ACCESSWIRE / December 7, 2024 / BioNxt Solutions Inc. (“BioNxt” or the “Company”) (CSE:BNXT)(OTCQB:XPHYF)(FSE:4XT), is pleased to announce today that it has … WebDec 23, 2024 · That is reason enough for Canadian biotech company BioNxt Solutions to further expand its strategic pole position. BioNxt Solutions secures further rights to a unique platform technology in this segment. Caution is currently the order of the day for MorphoSys. Analysts downgrade the target price from EUR 16 to EUR 12 after a … WebDec 31, 2024 · BioNxt Solutions Inc. meldete die Ergebnisse für das am 31. Dezember 2024 endende Geschäftsjahr. Für das Gesamtjahr meldete das Unternehmen einen … theta elite edge node